Literature DB >> 16408124

The association of serum lipids and inflammatory biomarkers with renal function in men with type II diabetes mellitus.

J Lin1, F B Hu, E B Rimm, N Rifai, G C Curhan.   

Abstract

Dyslipidemia and inflammation may promote renal disease via mechanisms of vascular endothelial cell dysfunction in type II diabetes mellitus (DM). Sparse data, however, are available on the relation of lipids and inflammatory biomarkers and glomerular filtration rate (GFR) in type II DM. We performed a cross-sectional study of 732 men with type II DM enrolled in the Health Professionals' Follow-Up Study. Plasma creatinine was used to estimate GFR by the simplified Modification of Diet in Renal Disease (MDRD) equation. In men with a GFR <60 ml/min/1.73 m(2), triglycerides, non-high-density lipoprotein (HDL), apoprotein B, fibrinogen, soluble tumor necrosis factor receptor (sTNFR-2) and vascular cell adhesion molecule-1 (VCAM) were significantly higher when compared to the referent group (GFR> or =90 ml/min/1.73 m(2)). In multivariable logistic regression, those in the highest quartiles of the following biomarkers had increased odds of having a GFR <60 ml/min/1.73 m(2) when compared to those in the lowest quartiles: triglycerides (odds ratio (OR) 3.11; 95% CI, 1.52-6.36), fibrinogen (OR 5.40; 95% CI 2.14-13.65), sTNFR-2 (OR 8.34; 95% CI 3.50-19.88) and VCAM (OR 4.50; 95% CI 1.98-10.23). An inverse association was observed for HDL (OR 0.48; 95% CI 0.24-0.98). We found no association between C-reactive protein and GFR. The results were similar when creatinine clearance by Cockcroft-Gault was used to estimate kidney function. We conclude that several potentially modifiable lipid and inflammatory biomarkers are elevated in the setting of moderately decreased GFR in men with type II DM and may be the link between renal insufficiency and increased risk for cardiovascular events in this population.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16408124      PMCID: PMC1630638          DOI: 10.1038/sj.ki.5000021

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  38 in total

Review 1.  Clinical practice. Nephropathy in patients with type 2 diabetes.

Authors:  Giuseppe Remuzzi; Arrigo Schieppati; Piero Ruggenenti
Journal:  N Engl J Med       Date:  2002-04-11       Impact factor: 91.245

2.  Stability of novel plasma markers associated with cardiovascular disease: processing within 36 hours of specimen collection.

Authors:  Jennifer K Pai; Gary C Curhan; Carolyn C Cannuscio; Nader Rifai; Paul M Ridker; Eric B Rimm
Journal:  Clin Chem       Date:  2002-10       Impact factor: 8.327

3.  Calcium intake and risk of colon cancer in women and men.

Authors:  Kana Wu; Walter C Willett; Charles S Fuchs; Graham A Colditz; Edward L Giovannucci
Journal:  J Natl Cancer Inst       Date:  2002-03-20       Impact factor: 13.506

4.  A prospective study of tomato products, lycopene, and prostate cancer risk.

Authors:  Edward Giovannucci; Eric B Rimm; Yan Liu; Meir J Stampfer; Walter C Willett
Journal:  J Natl Cancer Inst       Date:  2002-03-06       Impact factor: 13.506

5.  Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death.

Authors:  Coen D A Stehouwer; Mari-Anne Gall; Jos W R Twisk; Elisabeth Knudsen; Jef J Emeis; Hans-Henrik Parving
Journal:  Diabetes       Date:  2002-04       Impact factor: 9.461

6.  Circulating levels of ICAM-1, VCAM-1, and MCP-1 are increased in haemodialysis patients: association with inflammation, dyslipidaemia, and vascular events.

Authors:  Aikaterini Papayianni; Efstathios Alexopoulos; Panagiotis Giamalis; Lazaros Gionanlis; Anna-Maria Belechri; Paraschos Koukoudis; Dimitrios Memmos
Journal:  Nephrol Dial Transplant       Date:  2002-03       Impact factor: 5.992

7.  Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year.

Authors:  Patrizia Ziccardi; Francesco Nappo; Giovanni Giugliano; Katherine Esposito; Raffaele Marfella; Michele Cioffi; Francesco D'Andrea; Anna Maria Molinari; Dario Giugliano
Journal:  Circulation       Date:  2002-02-19       Impact factor: 29.690

8.  Inflammation, not hyperhomocysteinemia, is related to oxidative stress and hemostatic and endothelial dysfunction in uremia.

Authors:  D Mezzano; E O Pais; E Aranda; O Panes; P Downey; M Ortiz; R Tagle; F González; T Quiroga; M S Caceres; F Leighton; J Pereira
Journal:  Kidney Int       Date:  2001-11       Impact factor: 10.612

9.  C-reactive protein and interleukin-6 levels are related to renal function in predialytic chronic renal failure.

Authors:  Vincenzo Panichi; Massimiliano Migliori; Stefano De Pietro; Daniele Taccola; Anna Maria Bianchi; Luca Giovannini; Maria Norpoth; Maria Rita Metelli; Renza Cristofani; Alberto A E Bertelli; Giulietta Sbragia; Ciro Tetta; Roberto Palla; R Colombo
Journal:  Nephron       Date:  2002-08       Impact factor: 2.847

10.  Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency.

Authors:  Michael G Shlipak; Linda F Fried; Casey Crump; Anthony J Bleyer; Teri A Manolio; Russell P Tracy; Curt D Furberg; Bruce M Psaty
Journal:  Circulation       Date:  2003-01-07       Impact factor: 29.690

View more
  27 in total

1.  Predictive impact of elevated serum level of IL-18 for early renal dysfunction in type 2 diabetes: an observational follow-up study.

Authors:  S Araki; M Haneda; D Koya; T Sugimoto; K Isshiki; M Chin-Kanasaki; T Uzu; A Kashiwagi
Journal:  Diabetologia       Date:  2007-01-16       Impact factor: 10.122

Review 2.  Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials.

Authors:  Giovanni F M Strippoli; Sankar D Navaneethan; David W Johnson; Vlado Perkovic; Fabio Pellegrini; Antonio Nicolucci; Jonathan C Craig
Journal:  BMJ       Date:  2008-02-25

3.  Association of TNF Receptor 2 and CRP with GFR Decline in the General Nondiabetic Population.

Authors:  Jørgen Schei; Vidar Tor Nyborg Stefansson; Bjørn Odvar Eriksen; Trond Geir Jenssen; Marit Dahl Solbu; Tom Wilsgaard; Toralf Melsom
Journal:  Clin J Am Soc Nephrol       Date:  2017-02-02       Impact factor: 8.237

Review 4.  Novel biomarkers for the progression of diabetic nephropathy: soluble TNF receptors.

Authors:  Tomohito Gohda; Yasuhiko Tomino
Journal:  Curr Diab Rep       Date:  2013-08       Impact factor: 4.810

5.  Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes.

Authors:  Monika A Niewczas; Tomohito Gohda; Jan Skupien; Adam M Smiles; William H Walker; Florencia Rosetti; Xavier Cullere; John H Eckfeldt; Alessandro Doria; Tanya N Mayadas; James H Warram; Andrzej S Krolewski
Journal:  J Am Soc Nephrol       Date:  2012-01-19       Impact factor: 10.121

Review 6.  Should we use statins in all patients with chronic kidney disease without dialysis therapy? The current state of knowledge.

Authors:  Jacek Rysz; Anna Gluba-Brzózka; Maciej Banach; Andrzej Więcek
Journal:  Int Urol Nephrol       Date:  2015-03-11       Impact factor: 2.370

7.  Inflammation, kidney function and albuminuria in the Framingham Offspring cohort.

Authors:  Ashish Upadhyay; Martin G Larson; Chao-Yu Guo; Ramachandran S Vasan; Izabella Lipinska; Christopher J O'Donnell; Sekar Kathiresan; James B Meigs; John F Keaney; Jian Rong; Emelia J Benjamin; Caroline S Fox
Journal:  Nephrol Dial Transplant       Date:  2010-08-03       Impact factor: 5.992

8.  Serum concentrations of markers of TNFalpha and Fas-mediated pathways and renal function in nonproteinuric patients with type 1 diabetes.

Authors:  Monika A Niewczas; Linda H Ficociello; Amanda C Johnson; William Walker; Elizabeth T Rosolowsky; Bijan Roshan; James H Warram; Andrzej S Krolewski
Journal:  Clin J Am Soc Nephrol       Date:  2008-12-10       Impact factor: 8.237

9.  Tumor necrosis factor (TNF-alpha) and C-reactive protein (CRP) are positively associated with the risk of chronic kidney disease in patients with type 2 diabetes.

Authors:  Eun-Sil Yeo; Ji-Yun Hwang; Ji Eun Park; Young Ju Choi; Kap Bum Huh; Wha Young Kim
Journal:  Yonsei Med J       Date:  2010-07       Impact factor: 2.759

10.  Lipid and inflammatory biomarkers and kidney function decline in type 2 diabetes.

Authors:  J Lin; F B Hu; C Mantzoros; G C Curhan
Journal:  Diabetologia       Date:  2009-11-18       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.